(HealthDay)—The pooled prevalence of primary sclerosing cholangitis (PSC) is 2.16 percent in patients with inflammatory bowel disease (IBD), according to a review published in the December issue of Gastroenterology.
Nov 24, 2021
0
1
Crohn's disease and ulcerative colitis, chronic autoimmune disorders collectively known as inflammatory bowel disease (IBD), affect about 3 million Americans. They require a significant amount of medical management, sometimes ...
Nov 15, 2021
0
2
A research team at the Montreal Heart Institute and Université de Montréal has shown that genes present in specific intestinal cells protect against the development of inflammatory bowel diseases. Published today in the ...
Nov 12, 2021
0
136
APO-2 (Aposec) is a secretome-based trial preparation derived from stressed peripheral blood mononuclear cells. APO-2 was shown to be safe and effective in a multinational Phase I study in patients with diabetic foot ulcers ...
Nov 11, 2021
0
19
A new formulation developed by University of South Australia scientists to treat antimicrobial-resistant bacterial infections in diabetic foot ulcers could also be used to kill the COVID-19 virus circulating in air conditioning ...
Nov 11, 2021
0
71
Here's some comforting news for people who struggle with inflammatory bowel disease and worry that the immune-suppressing drugs they must take might blunt their response to COVID-19 vaccines: New research finds vaccination ...
Nov 4, 2021
0
11
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that use of platelet inhibitors could be associated with a reduction in the occurrence of digital ulcers, painful ...
Nov 1, 2021
0
2
The effectiveness of fecal microbiota transplantation (FMT) in treating ulcerative colitis depends on a small set of beneficial bacterial strains, suggests a new study from researchers at Weill Cornell Medicine and NewYork-Presbyterian.
Oct 12, 2021
0
21
(HealthDay)—The global prevalence of primary sclerosing cholangitis (PSC) ranges from 0.96 percent in Crohn disease (CD) to 2.47 percent in ulcerative colitis (UC), according to a review published online Aug. 19 in Gastroenterology.
Sep 27, 2021
0
16
New research being presented at the European Association for the Study of Diabetes (EASD), held online this year (27 Sept-1 Oct), reveals how Belgium's efforts to maintain a diabetic foot care program during the COVID-19 ...
Sep 27, 2021
0
2
